Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 3,295.40
+39.40 (1.21%)
Aug 13, 2025, 3:30 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 271.91 billion as of August 13, 2025. Its market cap has increased by 6.14% in one year.
Market Cap
271.91B
Enterprise Value
262.18B
Revenue
25.29B
Ranking
n/a
PE Ratio
52.95
Stock Price
3,295.40
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 271.91B, an increase of 298.80%. That is a compound annual growth rate of 15.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 271.91B | 8.76% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | 190.13B | 54.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,859.09B |
| Divi's Laboratories | 1,590.69B |
| Cipla | 1,215.50B |
| Apollo Hospitals Enterprise | 1,043.73B |
| Mankind Pharma | 1,006.03B |
| Zydus Lifesciences | 961.51B |
| Fortis Healthcare | 695.05B |
| Aurobindo Pharma | 611.53B |